8-K: Processa Pharma Relocates Special Stockholder Meeting

Processa Pharmaceuticals, Inc. announced a change in the physical location for its upcoming 2025 Special Meeting of Stockholders.

Summary

• Processa Pharmaceuticals, Inc. changed the location of its 2025 Special Meeting of Stockholders.
• The original meeting location, as disclosed in the proxy statement filed on August 13, 2025, was 601 21st Street, Suite 300, Vero Beach, FL 32960.
• The new location for the Special Meeting of Stockholders is 594 East Colorado Blvd. Suite 200 Pasadena, CA 91101.
• The Company's board of directors approved this location change on August 25, 2025.

Sentiment

Score: 5

Explanation: The filing reports a routine administrative change with no material positive or negative implications for the company's operations or financial health.

Future Outlook

The filing does not contain any forward-looking statements or guidance beyond the administrative change of the meeting location.

Management Comments

• The report was signed by George Ng, Chief Executive Officer.

Industry Context

This announcement is an administrative update regarding a corporate governance event and does not reflect broader industry trends or competitive dynamics within the pharmaceutical sector.

Corporate Governance

Stakeholder Impact

• Stockholders planning to attend the 2025 Special Meeting in person will need to adjust their travel plans to the new Pasadena, CA location.

Next Steps

• The 2025 Special Meeting of Stockholders will proceed at the newly announced location in Pasadena, CA.

Key Dates

Keywords

Processa Pharmaceuticals, PCSA, Special Meeting of Stockholders, Stockholder Meeting, Meeting Location Change, Corporate Governance, SEC Filing, 8-K